demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
lopinavir/ritonavir, ribavirin and interferon beta-1b Hung et al.

0 studies excluded by filtering options 0